Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Platelet Activation and Aggregation in Patients with Advanced Adenocarcinoma Undergoing Chemotherapy: Correlation with a Validated Venous Thromboembolism Risk Score

Arnab Basu, MD MPH, Rohit Gosain, MD, Udaya Tantry, PhD, Kenneth Miller, MD, Paul A Gurbel, MD

Blood (2015) 126 (23): 3445.

https://doi.org/10.1182/blood.V126.23.3445.3445

Published: 2015

Journal Articles

Largazole, a Novel Cyclic Peptide Histone Deacetylase Inhibitor, Demonstrates Anti-MM Effects Alone and Increases the Anti-MM Effects of Bortezomib.

Zhi-Wei Li, PhD, Mengyin Hu, Crystal Leung, Jeffrey A Steinberg, Jing Shen, Mingjie Li, Cathy S Wang, Eric Sanchez, Albert Bowers, Thomas Greshock, Kenneth Miller, Tenaya Newkirk, Nathan West, James E. Bradner, MD, Robert M Williams, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 4925.

https://doi.org/10.1182/blood.V114.22.4925.4925

Published: 2009

Journal Articles

Vaccination with DC/Multiple Myeloma Fusions in Conjunction with Stem Cell Transplantation.

David Avigan, MD, Jacalyn Rosenblatt, MD, Baldev Vasir, PhD, Zekui Wu, MD, Adam Bissonnette, Claire MacNamara, Lynne Uhl, MD, Corrine Lenahan, MD, Kenneth Miller, MD, James D. Levine, MD, Robin Joyce, MD, Karen Lowe, Dilani Dombagoda, Paul Richardson, MD, Kenneth Anderson, MD, Nikhil Munshi, MD, Donald Kuffe, MD

Blood (2007) 110 (11): 578.

https://doi.org/10.1182/blood.V110.11.578.578

Published: 2007

Journal Articles

Phase I Study of Vaccination with Dendritic Cell Myeloma Fusions.

David Avigan, MD, Jacalyn Rosenblatt, MD, Baldev Vasir, PhD, Zekui Wu, MD, Adam Bissonnette, Claire MacNamara, Lynne Uhl, MD, Corrinne Lenahan, MD, Kenneth Miller, MD, Robin Joyce, MD, James D. Levine, MD, Karen Lowe, RN, Dilani Dombagoda, Paul Richardson, MD, Kenneth Anderson, MD, Nikhil Munshi, Donald Kufe, MD

Blood (2007) 110 (11): 284.

https://doi.org/10.1182/blood.V110.11.284.284

Published: 2007

Journal Articles

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Jacalyn Rosenblatt, MD, Zekui Wu, MD, Corrine Lenahan, MD, Adam Bissonnette, Baldev Vasir, PhD, Kenneth Miller, MD, Robin Joyce, MD, James Levine, MD, Ilene Galinsky, RN, Richard Stone, MD, Donald Kufe, MD, David Avigan, MD

Blood (2007) 110 (11): 1794.

https://doi.org/10.1182/blood.V110.11.1794.1794

Published: 2007

Journal Articles

Vaccination with Dendritic Cell Myeloma Fusions Alone or in Conjunction with Stem Cell Transplantation for Patients with Multiple Myeloma.

David Avigan, MD, Jacalyn Rosenblatt, MD, Baldev Vasir, PhD, Zekui Wu, MD, Adam Bissonnette, Claire MacNamara, Lynne Uhl, MD, Corrine Lenahan, MD, Kenneth Miller, MD, Robin Joyce, MD, James D. Levine, MD, Joanne Proper, RN, Patricia Forino, RN, Dilani Dombagoda, Paul Richardson, MD, Nikhil C. Munshi, MD, Donald Kufe, MD

Blood (2006) 108 (11): 3080.

https://doi.org/10.1182/blood.V108.11.3080.3080

Published: 2006

Journal Articles

Leukemia Derived Dendritic Cells (LDCs) Are Functionally Deficient and Inferior to DC/Leukemia Fusion Cells as a Tumor Vaccine for AML.

Jacalyn Rosenblatt, MD, Richard Stone, MD, Corrine Lenahan, MD, Zekwui Wu, MD, Baldev Vasir, PhD, Daniel J. DeAngelo, MD, Ilene Galinsky, RN, Kenneth Miller, MD, James D. Levine, MD, Robin Joyce, MD, Donald Kufe, MD, David Avigan, MD

Blood (2005) 106 (11): 2788.

https://doi.org/10.1182/blood.V106.11.2788.2788

Published: 2005

Journal Articles

Frequency of Molecular and PET/CT Complete Remissions in Patients with Multiple Myeloma after Autologous Followed by Reduced-Intensity Allogeneic Stem Cell Transplants.

Ping Zhou, MD, PhD, Hugo Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, James W. Young, MD, Kenneth Miller, MD, Neeta Pandit-Taskar, MD, Daniel A. Filippa, MD, Martin Fleisher, PhD, Raymond L. Comenzo, MD

Blood (2004) 104 (11): 5113.

https://doi.org/10.1182/blood.V104.11.5113.5113

Published: 2004

Journal Articles

A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia

Charles A. Schiffer, Kenneth Miller, Richard A. Larson, Philip C. Amrein, Joseph H. Antin, Valter J. Zani, Richard M. Stone

Blood (2000) 95 (8): 2530–2535.

https://doi.org/10.1182/blood.V95.8.2530

Published: 2000

NARROW

Platelet Activation and Aggregation in Patients with Advanced Adenocarcinoma Undergoing Chemotherapy: Correlation with a Validated Venous Thromboembolism Risk Score

Largazole, a Novel Cyclic Peptide Histone Deacetylase Inhibitor, Demonstrates Anti-MM Effects Alone and Increases the Anti-MM Effects of Bortezomib.

Vaccination with DC/Multiple Myeloma Fusions in Conjunction with Stem Cell Transplantation.

Phase I Study of Vaccination with Dendritic Cell Myeloma Fusions.

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Vaccination with Dendritic Cell Myeloma Fusions Alone or in Conjunction with Stem Cell Transplantation for Patients with Multiple Myeloma.

Leukemia Derived Dendritic Cells (LDCs) Are Functionally Deficient and Inferior to DC/Leukemia Fusion Cells as a Tumor Vaccine for AML.

Frequency of Molecular and PET/CT Complete Remissions in Patients with Multiple Myeloma after Autologous Followed by Reduced-Intensity Allogeneic Stem Cell Transplants.

A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only